Olanzapine Injection, Powder, For Solution
Product Images NDC 0781-9105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0781-9105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapine 01)

FDA Label Image

Vial Label (Olanzapine 02)

Vial Label (Olanzapine 02)
This is a 10mg Olanzapine injection medication provided in a single use vial for intramuscular use only. The dosage and administration instructions should be referred to from the accompanying literature. It is manufactured by Gland Pharma Limited in Hyderabad, India for Sandoz Inc. in Princeton, NJ. The product is sterile and the NDC is 0781910572.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.